In this issue:
- Iron deficiency in HF
- Contemporary SGLT-2 inhibitor use in HF patients with diabetes
- Primary care HF service for identifying missed diagnoses of HFREF
- Renal dysfunction’s impact on cardiac outcomes and end-stage renal disease in HF with mitral regurgitation
- Weekend vs. weekday admissions for HF, with/without AF
- Long-term survival and life expectancy following acute HF hospitalisation
- Efficacy and safety of dapagliflozin in HF according to frailty
- Iron deficiency and anaemia in ambulatory chronic HF patients
Download Heart Failure Research Review, Issue 72, with commentary by Prof Andrew Coats

